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J Bligh, R Farrow
Three weeks ago (BMJ 2003;326:588) we published the
case of Ruth, who presented to her general practitioner
with a rash after feeling unwell for some time. She had
dermatomyositis diagnosed and, during investigation
for possible underlying causes, was found to have an
aneurysm of the splenic artery (BMJ 2003;326:640).
Ruth’s case was discussed at a multidisciplinary
meeting and a decision was made to treat her
aneurysm with a covered stent placed under fluoro-
scopic guidance by a radiologist. A theatre space was
booked for the same time as the procedure in case of
complications. She had a repeat angiogram and a wire
was passed across the aneurysm.
Surgery and follow up
Two covered stents were placed across the neck of the
aneurysm and a repeat contrast injection showed that
there was no communication between the splenic
artery and the aneurysm sac (figure). Ultrasonography
the next day showed the aneurysm filled with
thrombus with no flow on colour Doppler. The follow-
ing day contrast enhanced computed tomography
showed no evidence of a leak. Follow up computed
tomography continued to show no leak and no flow in
the aneurysm sac. Ruth was given pneumococcal and
haemophilus influenza vaccines as a prophylactic
measure in case of future hyposplenism caused by
migration or occlusion of the stent.
As it was envisaged that Ruth would be taking
steroids long term, she was referred for bone
densitometry (dual x ray absorptiometry), which
showed no evidence of osteoporosis. Ruth was
reassured but advised that it would be sensible to
increase her calcium intake to 1500 mg a day. She
found this difficult to achieve and so was started on an
oral calcium and vitamin D supplement. She was also
advised to take as much weight bearing exercise as
possible. The steroid dose was kept as low as possible.
A further consideration is whether Ruth’s relatives
should be screened as she and her sister have both had
aneurysms.
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Commentary: Patient’s perspective
Ruth with the support of Richard Farrow
I have found being involved in this new interactive
report very interesting. I wanted to put something
back. My doctors have been marvellous and have done
everything possible to help me. Right from my first
consultation, my general practitioner told me what he
thought I had and said that I should see a dermatolo-
gist at the hospital. I had only just got home when he
telephoned with the appointment date.
It’s better to know
How have I felt about my condition being discussed?
Well I am happy to have all this discussion about my
condition. I would prefer to know what is going on and
often talk to my husband about these things.
Nevertheless, the comments on the web have reminded
me that I have a few unusual complaints—it would be
nice to have something common and ordinary.
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There have been a few comments about my mam-
mogram. I would like to say that I really believe in
screening and am screened regularly. If they made it
compulsory, I would be close to the front of the line.
Other doctors seem to feel that I should not have been
told about the risk of cancer with the dermatomyositis.
I think this is wrong; it is better to know so that you
understand why you have been referred for all these
tests. It is better to be prepared from an early stage. It’s
not as if I don’t have experience of cancer; my mother
and grandfather both died of bowel cancer.
Many of the contributors ask about weakness in my
muscles. This was not really an issue at the start. It was
just my rash. But now I am beginning to have difficulties
in walking up the stairs.
There were several comments about the aneurysm.
My friends were very worried and felt that I should not
go out on my own. My husband even talked about giv-
ing up bowls, but what was the point? He could have
been mowing the lawn, and if I was inside and
collapsed, he still could not have helped.
It has been interesting to see comments from
around the world. It has also let me as a patient have
insight into what a doctor is thinking. The doctors are
talking to you about one thing, perhaps your rash, and
thinking something completely different, such as does
she have cancer.
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Commentary: Vascular surgeon
Linda Hands
Splenic artery aneurysms are an incidental finding in
almost 1% of abdominal angiograms. They are usually
less than 2 cm in diameter and often affect the distal
splenic artery. Their association with multiple preg-
nancies partly explains why they are four times
commoner in women than men. Other documented
associations include pancreatitis, portal hypertension,
trauma, and, with possible relevance to Ruth, systemic
lupus erythematosus.1
The main risk is of rupture, and a lifetime rupture
rate of 2-10% is often quoted. Although this is not
based on hard prospective data, large splenic artery
aneurysms such as Ruth’s (which was about 10 cm
in diameter) carry at least a 10% risk. Coexistent
inflammatory conditions such as dermatomyositis
may increase that risk. If Ruth’s aneurysm had
ruptured, her chance of survival would have been
about 75%.2
Different treatment options
The rapid responses on bmj.com illustrated the differ-
ent treatment options for these aneurysms.One option
is to sit tight on the assumption that the risk of rupture
is low and that of intervention relatively high. The tra-
ditional surgical approach is laparotomy and ligation
of the arteries proximal and distal to the aneurysm,
possibly with splenectomy if the aneurysm is in the
hilum of the spleen. Ligation can also be achieved
laparoscopically without a large abdominal incision.3
Endovascular approaches include placing a stent graft
across the aneurysm to exclude the expanded lumen4
or coiling the splenic artery to thrombose the
aneurysm.5
Sitting tight was not a viable option in Ruth’s case
because of the high risk of rupture. Open surgery
would not have been easy because the aneurysm was
large and likely to be stuck to the stomach and colon
and difficult to remove from the pancreas. Open
surgery may also be associated with poor wound
healing, chest infection, and deep vein thrombosis.
When the spleen has to be removed, a subphrenic
abscess may form on the splenic bed, and there is a
long term risk of increased infection. A laparoscopic
approach would have been difficult with such a large
aneurysm.
Endovascular occlusion of the aneurysm was
another option. But instrumentation of the splenic
artery and aneurysm may precipitate rupture, dissec-
tion, or distal embolisation of the spleen leading to
infarction and pain and possibly some of the
complications associated with splenectomy. It would
also have been difficult, given the large size of the
aneurysm, and recanalisation has been shown in
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such cases. Stent grafting, however, is successful with
large visceral aneurysms,4 and it is not surprising that
this was considered the best treatment for Ruth.
Follow up
In future, Ruth should have annual computed tomo-
graphy scans to check that the stent remains in the
right position and check for the development of
further aneurysms.
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Commentary: Dermatology
Natasha Kapur, Malcolm H A Rustin
Although dermatomyositis is rare, its cutaneous signs
are characteristic. It was therefore not surprising that
two thirds of the responses to the initial presentation of
Ruth’s case agreed with the general practitioner’s pro-
visional diagnosis. In classic cases a purplish-red helio-
trope erythema occurs on the eyelids, upper cheeks,
forehead, and temples. Small, erythematous or
violaceous, flat papules (Gottron’s papules) and small
plaques occur over the knuckles and on the dorsal sur-
face of the finger joints. This is associated with aching
and muscle weakness, which may appear later, and in
time results in muscle atrophy.
The diagnosis is confirmed by muscle biopsy,
electromyography, and raised serum concentrations
of creatine phosphokinase. Glutamic oxalacetic
transaminase concentrations are often also raised. The
cause is unknown, but there is increasing evidence of
early damage to blood vessels, probably humorally
mediated.1
Neoplasia
The overall incidence of underlying neoplasia in
reported series varies from 29% to 40% of patients
aged over 40 years. The primary tumour most
commonly occurs in the lung, breast, female genital
tract, stomach, rectum, kidneys, or testis. In Chinese
people, nasopharyngeal carcinoma is the commonest
underlying malignant disease. The condition may also
be associated with lymphomas.2 Dermatomyositis
precedes the neoplasm in 40% of cases.3
Neoplasia seems to be more common in men than
women.4 Skin manifestations tend to worsen in parallel
with the growth of the neoplasm but may improve
when the cancer is treated. Neoplasia may be missed
because of failure to reinvestigate relapse of previously
stable dermatomyositis.5 Ruth has a strong family
history of cancer and therefore she should be offered
regular screening tests, including chest radiography,
mammography, pelvic ultrasonography and a test or
tests for tumour markers. The advice that several
respondents gave about sun protection is essential, and
Ruth should be reassured that she cannot pass the
condition on to her children.
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Commentary: View from primary care
John Benson
As Ruth’s case has unfolded her general practitioner
has had several issues to discuss with her. Her initial
presentation was unusual, and as responders to
bmj.com underlined, her general practitioner did well
to make a provisional diagnosis of dermatomyositis.
But even in the absence of a working diagnosis, it was
evident that Ruth needed urgent investigation. Many
respondents reflected on the appropriate extent of
investigation before referral to a specialist. Some men-
tioned the possibility of diagnostic support via the
web. Pictures are available at http://dermis.
multimedica.de (a commercially sponsored site) and
www.gpnotebook.co.uk offers accessible information,
although not its evidence base.
What to tell Ruth
Once the diagnosis of dermatomyositis had been
raised, there was the difficult question of what to tell
Ruth about the link with malignancy. General
practitioners do not carry figures for this in their
heads, and although Medline is accessible, it takes time
to appraise. Many patients (though not all) want us to
discuss unpleasant possibilities openly.1 The general
practitioner had to judge what Ruth wanted to know,
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calling for good communication skills including
possible admission of uncertainty. Sharing the referral
letter to secondary care may help transparency.2
While Ruth was having extensive investigation in
hospital, it will have been important to ensure that the
information she was given from general practice was
consistent with what the hospital was telling her and
that her perceptions and concerns were being
addressed. Although Ruth’s stenting was planned at a
case conference, her informed consent to the interven-
tion required sharing decision making. The best way to
do this is open to debate,3 and many patients turn to
their general practitioners before making their mind
up. Prompt and clear communication between special-
ists and general practitioners and delineation about
who is doing what—for example, regarding
vaccination4—is vital.
Ruth experienced adverse effects from azathioprine
and risks more while she continues taking steroids. The
aims, risks, and benefits of treatment need to be
discussed with her, because her views will ultimately
determine whether she takes prescribed drugs.5
Because Ruth is receiving ongoing treatment with
steroids her general practitioner must monitor her for
glucose intolerance and hypertension and consider
treatment to prevent osteoporosis. Two recent reviews
are relevant for steroid induced osteoporosis,6 7 and
Ruth may find the support of the National Osteoporo-
sis Society (www.nos.org.uk) helpful. Ruth’s percep-
tions and those of her general practitioner about new
symptoms will be influenced by this illness: although
her condition is unusual, many of the issues it has
raised in general practice are common.
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Commentary: Learning from interactive case reports
Ed Peile
Ten days after Ruth’s case was published, over 60
doctors had engaged in the web discussion around diag-
nosis, investigation, and patient communication. A wide
range of specialties has been represented, and just over a
third of the contributors work outside the United King-
dom. One of the aims of publishing interactive case
reports is to encourage interdisciplinary learning, and it
has been good to see the process in action.
Communication with the patient has been a major
focus. “To know what I would tell Ruth at this stage, I
need to know what she wants to know. . .What are her
concerns and expectations?” asked Judith Harvey. We
then heard from Ruth, and her perspectives were
illuminating. Whereas doctors were expressing con-
cern about her risk of developing malignancy, she was
worrying about steroid induced cataracts.
John McCormack observed that hospital specialists
seemed much keener to share their worries with the
patient at an early stage than general practitioners.
Only one out of 19 general practitioners favoured tell-
ing Ruth about the possibility of malignancy when she
first presented with dermatomyositis, compared with
seven out of 11 specialists.
Subtle differences in approach
A web forum where primary and secondary care phy-
sicians can discover subtle differences in their
approaches is, for me, an important feature of this new
learning exercise. I was therefore interested in the dia-
logue on how many investigations the general
practitioner should do. Liam Farrell favoured prompt
referral to secondary care. Jan Van Hollebeke, by con-
trast, suggested that the general practitioner needed to
take simple blood tests straight away so that Ruth could
make “an evidence based informed decision” about
how she should be investigated further.
Stuart Skeates, a general practitioner, and Colin
White, a physician, considered what investigations are
helpful for dermatomyositis. After reading the wide
diversity of opinions on this on the web, I found
Natasha Kapur’s expert commentary helpful. Simi-
larly, Linda Hand’s synthesis has helped me see more
clearly after the technical debate on the web around
vascular surgery and interventional radiology.
Can we learn from rare conditions? There were
pleas that “Trafalgar Square pigeons” make for better
learning than “lesser spotted, greater crested grebes”—
and that was before the discovery of Ruth’s splenic
artery aneurysm. It is a fair point, but others found this
case challenging and interesting precisely because it
has been a bit out of the ordinary. We certainly need
plenty of case material around bread and butter medi-
cine. What this case has managed to do, however, is to
provoke a rich response from a wide range doctors,
and I look forward to the next one.
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